Esphera SynBio

Esphera SynBio is a synthetic biology company developing engineered exosomes as nanomedicines for cancer and infectious diseases. They utilize proprietary transgenes to generate therapeutic exosomes in vivo, creating innovative vaccine and immunotherapy solutions. The company's technology platform unlocks new possibilities in vaccine innovation and personalized medicine.

Buy Funded Startups lists

Funding Round: Seed

Funding Amount: $2M

Date: 07-Jan-2025

Investors: GKCC, FACIT

Markets: Biotechnology, Synthetic Biology, Immunotherapy, Vaccines

HQ: Ottawa, Ontario, Canada

Founded: 2022

Website: https://espherasynbio.ca/

LinkedIn: https://ca.linkedin.com/company/esphera-synbio-inc

Twitter:

Instagram: